Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 984 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib N-Glucuronide-1 (Intedanib N-Glucuronide) REF: 4Z-N-066022	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 61 REF: 4Z-O-032066CAS: 59878-57-8	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 40 REF: 4Z-E-068053CAS: 1895865-11-8	- - -	To inquire	Thu 19 Dec 24
Olaparib REF: TM-T3015CAS: 763113-22-0	100% - 99.90%	37.00 €~234.00 €	Thu 19 Dec 24
Fulvestrant Enantiomer REF: 4Z-F-3139	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 34 REF: 4Z-N-066051CAS: 2036139-30-5	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 20 REF: 4Z-N-066034CAS: 1912-28-3	- - -	To inquire	Thu 19 Dec 24
N1, N2-Di-Nitroso Palbociclib REF: 4Z-P-196083	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 60 REF: 4Z-P-196067CAS: 2488840-59-9	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 36 REF: 4Z-O-032041	- - -	To inquire	Thu 19 Dec 24
Goserelin EP Impurity C REF: 4Z-PG-1510	- - -	To inquire	Thu 19 Dec 24
Abiraterone Impurity 17 REF: 4Z-A-8255CAS: 154229-21-7	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 28 REF: 4Z-C-121031CAS: 143415-51-4	- - -	To inquire	Thu 19 Dec 24
Gimeracil Impurity 2 REF: 4Z-G-047002	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 4 REF: 4Z-O-032006CAS: 1021298-68-9	- - -	To inquire	Thu 19 Dec 24
Lenvatinib-d5 REF: 4Z-L-124056	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 29 REF: 4Z-C-121032	- - -	To inquire	Thu 19 Dec 24
Tamoxifen N-oxide REF: 4Z-T-0111CAS: 75504-34-6	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 45 REF: 4Z-P-196052CAS: 193902-78-2	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 75 REF: 4Z-C-121078	- - -	To inquire	Thu 19 Dec 24

1g		234.00 €
5mg		37.00 €
10mg		53.00 €
50mg		75.00 €
100mg		90.00 €
200mg		118.00 €
500mg		170.00 €

Cancer treatment

Nintedanib N-Glucuronide-1 (Intedanib N-Glucuronide)

Ref: 4Z-N-066022

Olaparib Impurity 61

Ref: 4Z-O-032066

Enzalutamide Impurity 40

Ref: 4Z-E-068053

Olaparib

Ref: TM-T3015

Fulvestrant Enantiomer

Ref: 4Z-F-3139

Nintedanib Impurity 34

Ref: 4Z-N-066051

Nintedanib Impurity 20

Ref: 4Z-N-066034

N1, N2-Di-Nitroso Palbociclib

Ref: 4Z-P-196083

Palbociclib Impurity 60

Ref: 4Z-P-196067

Olaparib Impurity 36

Ref: 4Z-O-032041

Goserelin EP Impurity C

Ref: 4Z-PG-1510

Abiraterone Impurity 17

Ref: 4Z-A-8255

Carfilzomib Impurity 28

Ref: 4Z-C-121031

Gimeracil Impurity 2

Ref: 4Z-G-047002

Olaparib Impurity 4

Ref: 4Z-O-032006

Lenvatinib-d5

Ref: 4Z-L-124056

Carfilzomib Impurity 29

Ref: 4Z-C-121032

Tamoxifen N-oxide

Ref: 4Z-T-0111

Palbociclib Impurity 45

Ref: 4Z-P-196052

Carfilzomib Impurity 75

Ref: 4Z-C-121078